Search - tctmd.com

Displaying 61 - 80 of 970

Sort: Relevancy | Date

News Daily News

What’s the Damage With Long COVID? Advanced Imaging Reveals Clues

Caitlin E. Cox

May 27, 2025

News Conference News ESOC 2025

Don’t Forget to Floss! Better Oral Hygiene May Help Stave Off Stroke

Todd Neale

May 23, 2025

News Conference News EuroPCR 2025

Higher Mortality With TAVI Over Surgery in Bicuspid Aortic Stenosis

Michael O'Riordan

May 22, 2025

News Opinion CV Team Dispatch

May 2025 Dispatch for the CV Team

L.A. McKeown

May 20, 2025

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Conference News EAS 2025

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

Yael L. Maxwell

May 08, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Daily News

HDL Cholesterol Levels May Sway Statin Decisions in Primary Prevention

Michael O'Riordan

May 02, 2025

News Daily News

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

Yael L. Maxwell

April 29, 2025

News Conference News HRS 2025

GLP-1 Drugs May Have Role in Secondary Prevention of AF

Todd Neale

April 28, 2025

News Daily News

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Michael O'Riordan

April 25, 2025

News Daily News

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

Caitlin E. Cox

April 23, 2025

News Daily News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Michael O'Riordan

April 22, 2025

News Daily News

High-Sensitivity Troponin Tests Might Aid in Primary Prevention

Yael L. Maxwell

April 16, 2025

News Daily News

Cardiotoxicity Rare With Common GI Chemotherapy

L.A. McKeown

April 15, 2025

News Conference News ACC 2025

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

L.A. McKeown

April 10, 2025

News Conference News ACC 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

Michael O'Riordan

April 02, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Conference News CRT 2025

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

L.A. McKeown

March 12, 2025

Advertisement

What’s the Damage With Long COVID? Advanced Imaging Reveals Clues

Don’t Forget to Floss! Better Oral Hygiene May Help Stave Off Stroke

Higher Mortality With TAVI Over Surgery in Bicuspid Aortic Stenosis

May 2025 Dispatch for the CV Team

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

HDL Cholesterol Levels May Sway Statin Decisions in Primary Prevention

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

GLP-1 Drugs May Have Role in Secondary Prevention of AF

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

High-Sensitivity Troponin Tests Might Aid in Primary Prevention

Cardiotoxicity Rare With Common GI Chemotherapy

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content